Industry Research Reports

Home > Reports > Pharma & Healthcare > Hydroxychloroquine (Plaquenil) - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Hydroxychloroquine (Plaquenil) - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Industry: Pharma & Healthcare

Published: 2024-01-14

Pages: 165 Pages

Report ld: 2632035

Description
Table of Contents
Table of Figures
PDF Download

Description
Table of Contents
Table of Figures
PDF Download

Description

Hydroxychloroquine is a racemic mixture consisting of an R and S enantiomer.2 Hydroxychloroquine is an aminoquinoline like chloroquine. It is a commonly prescribed medication in the treatment of uncomplicated malaria, rheumatoid arthritis, chronic discoid lupus erythematosus, and systemic lupus erythematosus. Hydroxychloroquine is also used for the prophylaxis of malaria in regions where chloroquine resistance is unlikely. It was developed during World War II as a derivative of quinacrine with less severe side effects.6 Chloroquine and hydroxychloroquine are both being investigated for the treatment of SARS-CoV-2.7It is taken by mouth.[2] It is also being used as an experimental treatment for coronavirus disease 2019 (COVID-19).

The global market for Hydroxychloroquine (Plaquenil) was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.

North American market for Hydroxychloroquine (Plaquenil) was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Hydroxychloroquine (Plaquenil) was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Europe market for Hydroxychloroquine (Plaquenil) was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The global key companies of Hydroxychloroquine (Plaquenil) include Sanofi, Actavis (TEVA ), Mylan, Novartis, Covis Pharmaceutical, Cardinal Health, Apotex Corporation, Hikma Pharmaceuticals and Aphena Pharma, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.

Report Scope
This report aims to provide a comprehensive presentation of the global market for Hydroxychloroquine (Plaquenil), focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Hydroxychloroquine (Plaquenil) by region & country, by Type, and by Application.

The Hydroxychloroquine (Plaquenil) market size, estimations, and forecasts are provided in terms of sales volume (M Pcs) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hydroxychloroquine (Plaquenil).

Market Segmentation

Report Metric
Details
Report Title
Hydroxychloroquine (Plaquenil) - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Global Hydroxychloroquine (Plaquenil) Companies Covered
Sanofi, Actavis (TEVA ), Mylan, Novartis, Covis Pharmaceutical, Cardinal Health, Apotex Corporation, Hikma Pharmaceuticals, Aphena Pharma, Concordia Healthcare, AvKARE (Amneal Pharmaceuticals), Ipca Laboratories, Shanghai Pharmaceuticals Holding, Taj Pharmaceuticals, Cinkate Corporation, Cadila Healthcare, Sun Pharma, Zydus Cadila, Advanz Pharma, Bristol Laboratories, Hanlim Pharmaceutical, Kyung Poong
Global Hydroxychloroquine (Plaquenil) Market, by Region
North America (U.S., Canada, Mexico)

Europe (Germany, France, UK, Italy, etc.)

Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)

South America (Brazil, etc.)

Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Hydroxychloroquine (Plaquenil) Market, Segment by Type
100mg

200mg

Other
Global Hydroxychloroquine (Plaquenil) Market, Segment by Application
Lupus Erythematosus

Rheumatoid Arthritis

COVID-19

Others
Forecast Units
USD million in value
Report Coverage
Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Hydroxychloroquine (Plaquenil) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Hydroxychloroquine (Plaquenil) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Hydroxychloroquine (Plaquenil) in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Table of Contents

 1 Market Overview
    1.1 Hydroxychloroquine (Plaquenil) Product Introduction
    1.2 Global Hydroxychloroquine (Plaquenil) Market Size Forecast
        1.2.1 Global Hydroxychloroquine (Plaquenil) Sales Value (2019-2030)
        1.2.2 Global Hydroxychloroquine (Plaquenil) Sales Volume (2019-2030)
        1.2.3 Global Hydroxychloroquine (Plaquenil) Sales Price (2019-2030)
    1.3 Hydroxychloroquine (Plaquenil) Market Trends & Drivers
        1.3.1 Hydroxychloroquine (Plaquenil) Industry Trends
        1.3.2 Hydroxychloroquine (Plaquenil) Market Drivers & Opportunity
        1.3.3 Hydroxychloroquine (Plaquenil) Market Challenges
        1.3.4 Hydroxychloroquine (Plaquenil) Market Restraints
    1.4 Assumptions and Limitations
    1.5 Study Objectives
    1.6 Years Considered

 2 Competitive Analysis by Company
    2.1 Global Hydroxychloroquine (Plaquenil) Players Revenue Ranking (2023)
    2.2 Global Hydroxychloroquine (Plaquenil) Revenue by Company (2019-2024)
    2.3 Global Hydroxychloroquine (Plaquenil) Players Sales Volume Ranking (2023)
    2.4 Global Hydroxychloroquine (Plaquenil) Sales Volume by Company Players (2019-2024)
    2.5 Global Hydroxychloroquine (Plaquenil) Average Price by Company (2019-2024)
    2.6 Key Manufacturers Hydroxychloroquine (Plaquenil) Manufacturing Base Distribution and Headquarters
    2.7 Key Manufacturers Hydroxychloroquine (Plaquenil) Product Offered
    2.8 Key Manufacturers Time to Begin Mass Production of Hydroxychloroquine (Plaquenil)
    2.9 Hydroxychloroquine (Plaquenil) Market Competitive Analysis
        2.9.1 Hydroxychloroquine (Plaquenil) Market Concentration Rate (2019-2024)
        2.9.2 Global 5 and 10 Largest Manufacturers by Hydroxychloroquine (Plaquenil) Revenue in 2023
        2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hydroxychloroquine (Plaquenil) as of 2023)
    2.10 Mergers & Acquisitions, Expansion

 3 Segmentation by Type
    3.1 Introduction by Type
        3.1.1 100mg
        3.1.2 200mg
        3.1.3 Other
    3.2 Global Hydroxychloroquine (Plaquenil) Sales Value by Type
        3.2.1 Global Hydroxychloroquine (Plaquenil) Sales Value by Type (2019 VS 2023 VS 2030)
        3.2.2 Global Hydroxychloroquine (Plaquenil) Sales Value, by Type (2019-2030)
        3.2.3 Global Hydroxychloroquine (Plaquenil) Sales Value, by Type (%) (2019-2030)
    3.3 Global Hydroxychloroquine (Plaquenil) Sales Volume by Type
        3.3.1 Global Hydroxychloroquine (Plaquenil) Sales Volume by Type (2019 VS 2023 VS 2030)
        3.3.2 Global Hydroxychloroquine (Plaquenil) Sales Volume, by Type (2019-2030)
        3.3.3 Global Hydroxychloroquine (Plaquenil) Sales Volume, by Type (%) (2019-2030)
    3.4 Global Hydroxychloroquine (Plaquenil) Average Price by Type (2019-2030)

 4 Segmentation by Application
    4.1 Introduction by Application
        4.1.1 Lupus Erythematosus
        4.1.2 Rheumatoid Arthritis
        4.1.3 COVID-19
        4.1.4 Others
    4.2 Global Hydroxychloroquine (Plaquenil) Sales Value by Application
        4.2.1 Global Hydroxychloroquine (Plaquenil) Sales Value by Application (2019 VS 2023 VS 2030)
        4.2.2 Global Hydroxychloroquine (Plaquenil) Sales Value, by Application (2019-2030)
        4.2.3 Global Hydroxychloroquine (Plaquenil) Sales Value, by Application (%) (2019-2030)
    4.3 Global Hydroxychloroquine (Plaquenil) Sales Volume by Application
        4.3.1 Global Hydroxychloroquine (Plaquenil) Sales Volume by Application (2019 VS 2023 VS 2030)
        4.3.2 Global Hydroxychloroquine (Plaquenil) Sales Volume, by Application (2019-2030)
        4.3.3 Global Hydroxychloroquine (Plaquenil) Sales Volume, by Application (%) (2019-2030)
    4.4 Global Hydroxychloroquine (Plaquenil) Average Price by Application (2019-2030)

 5 Segmentation by Region
    5.1 Global Hydroxychloroquine (Plaquenil) Sales Value by Region
        5.1.1 Global Hydroxychloroquine (Plaquenil) Sales Value by Region: 2019 VS 2023 VS 2030
        5.1.2 Global Hydroxychloroquine (Plaquenil) Sales Value by Region (2019-2024)
        5.1.3 Global Hydroxychloroquine (Plaquenil) Sales Value by Region (2025-2030)
        5.1.4 Global Hydroxychloroquine (Plaquenil) Sales Value by Region (%), (2019-2030)
    5.2 Global Hydroxychloroquine (Plaquenil) Sales Volume by Region
        5.2.1 Global Hydroxychloroquine (Plaquenil) Sales Volume by Region: 2019 VS 2023 VS 2030
        5.2.2 Global Hydroxychloroquine (Plaquenil) Sales Volume by Region (2019-2024)
        5.2.3 Global Hydroxychloroquine (Plaquenil) Sales Volume by Region (2025-2030)
        5.2.4 Global Hydroxychloroquine (Plaquenil) Sales Volume by Region (%), (2019-2030)
    5.3 Global Hydroxychloroquine (Plaquenil) Average Price by Region (2019-2030)
    5.4 North America
        5.4.1 North America Hydroxychloroquine (Plaquenil) Sales Value, 2019-2030
        5.4.2 North America Hydroxychloroquine (Plaquenil) Sales Value by Country (%), 2023 VS 2030
    5.5 Europe
        5.5.1 Europe Hydroxychloroquine (Plaquenil) Sales Value, 2019-2030
        5.5.2 Europe Hydroxychloroquine (Plaquenil) Sales Value by Country (%), 2023 VS 2030
    5.6 Asia Pacific
        5.6.1 Asia Pacific Hydroxychloroquine (Plaquenil) Sales Value, 2019-2030
        5.6.2 Asia Pacific Hydroxychloroquine (Plaquenil) Sales Value by Country (%), 2023 VS 2030
    5.7 South America
        5.7.1 South America Hydroxychloroquine (Plaquenil) Sales Value, 2019-2030
        5.7.2 South America Hydroxychloroquine (Plaquenil) Sales Value by Country (%), 2023 VS 2030
    5.8 Middle East & Africa
        5.8.1 Middle East & Africa Hydroxychloroquine (Plaquenil) Sales Value, 2019-2030
        5.8.2 Middle East & Africa Hydroxychloroquine (Plaquenil) Sales Value by Country (%), 2023 VS 2030

 6 Segmentation by Key Countries/Regions
    6.1 Key Countries/Regions Hydroxychloroquine (Plaquenil) Sales Value Growth Trends, 2019 VS 2023 VS 2030
    6.2 Key Countries/Regions Hydroxychloroquine (Plaquenil) Sales Value
        6.2.1 Key Countries/Regions Hydroxychloroquine (Plaquenil) Sales Value, 2019-2030
        6.2.2 Key Countries/Regions Hydroxychloroquine (Plaquenil) Sales Volume, 2019-2030
    6.3 United States
        6.3.1 United States Hydroxychloroquine (Plaquenil) Sales Value, 2019-2030
        6.3.2 United States Hydroxychloroquine (Plaquenil) Sales Value by Type (%), 2023 VS 2030
        6.3.3 United States Hydroxychloroquine (Plaquenil) Sales Value by Application, 2023 VS 2030
    6.4 Europe
        6.4.1 Europe Hydroxychloroquine (Plaquenil) Sales Value, 2019-2030
        6.4.2 Europe Hydroxychloroquine (Plaquenil) Sales Value by Type (%), 2023 VS 2030
        6.4.3 Europe Hydroxychloroquine (Plaquenil) Sales Value by Application, 2023 VS 2030
    6.5 China
        6.5.1 China Hydroxychloroquine (Plaquenil) Sales Value, 2019-2030
        6.5.2 China Hydroxychloroquine (Plaquenil) Sales Value by Type (%), 2023 VS 2030
        6.5.3 China Hydroxychloroquine (Plaquenil) Sales Value by Application, 2023 VS 2030
    6.6 Japan
        6.6.1 Japan Hydroxychloroquine (Plaquenil) Sales Value, 2019-2030
        6.6.2 Japan Hydroxychloroquine (Plaquenil) Sales Value by Type (%), 2023 VS 2030
        6.6.3 Japan Hydroxychloroquine (Plaquenil) Sales Value by Application, 2023 VS 2030
    6.7 South Korea
        6.7.1 South Korea Hydroxychloroquine (Plaquenil) Sales Value, 2019-2030
        6.7.2 South Korea Hydroxychloroquine (Plaquenil) Sales Value by Type (%), 2023 VS 2030
        6.7.3 South Korea Hydroxychloroquine (Plaquenil) Sales Value by Application, 2023 VS 2030
    6.8 Southeast Asia
        6.8.1 Southeast Asia Hydroxychloroquine (Plaquenil) Sales Value, 2019-2030
        6.8.2 Southeast Asia Hydroxychloroquine (Plaquenil) Sales Value by Type (%), 2023 VS 2030
        6.8.3 Southeast Asia Hydroxychloroquine (Plaquenil) Sales Value by Application, 2023 VS 2030
    6.9 India
        6.9.1 India Hydroxychloroquine (Plaquenil) Sales Value, 2019-2030
        6.9.2 India Hydroxychloroquine (Plaquenil) Sales Value by Type (%), 2023 VS 2030
        6.9.3 India Hydroxychloroquine (Plaquenil) Sales Value by Application, 2023 VS 2030

 7 Company Profiles
    7.1 Sanofi
        7.1.1 Sanofi Company Information
        7.1.2 Sanofi Introduction and Business Overview
        7.1.3 Sanofi Hydroxychloroquine (Plaquenil) Sales, Revenue and Gross Margin (2019-2024)
        7.1.4 Sanofi Hydroxychloroquine (Plaquenil) Product Offerings
        7.1.5 Sanofi Recent Development
    7.2 Actavis (TEVA )
        7.2.1 Actavis (TEVA ) Company Information
        7.2.2 Actavis (TEVA ) Introduction and Business Overview
        7.2.3 Actavis (TEVA ) Hydroxychloroquine (Plaquenil) Sales, Revenue and Gross Margin (2019-2024)
        7.2.4 Actavis (TEVA ) Hydroxychloroquine (Plaquenil) Product Offerings
        7.2.5 Actavis (TEVA ) Recent Development
    7.3 Mylan
        7.3.1 Mylan Company Information
        7.3.2 Mylan Introduction and Business Overview
        7.3.3 Mylan Hydroxychloroquine (Plaquenil) Sales, Revenue and Gross Margin (2019-2024)
        7.3.4 Mylan Hydroxychloroquine (Plaquenil) Product Offerings
        7.3.5 Mylan Recent Development
    7.4 Novartis
        7.4.1 Novartis Company Information
        7.4.2 Novartis Introduction and Business Overview
        7.4.3 Novartis Hydroxychloroquine (Plaquenil) Sales, Revenue and Gross Margin (2019-2024)
        7.4.4 Novartis Hydroxychloroquine (Plaquenil) Product Offerings
        7.4.5 Novartis Recent Development
    7.5 Covis Pharmaceutical
        7.5.1 Covis Pharmaceutical Company Information
        7.5.2 Covis Pharmaceutical Introduction and Business Overview
        7.5.3 Covis Pharmaceutical Hydroxychloroquine (Plaquenil) Sales, Revenue and Gross Margin (2019-2024)
        7.5.4 Covis Pharmaceutical Hydroxychloroquine (Plaquenil) Product Offerings
        7.5.5 Covis Pharmaceutical Recent Development
    7.6 Cardinal Health
        7.6.1 Cardinal Health Company Information
        7.6.2 Cardinal Health Introduction and Business Overview
        7.6.3 Cardinal Health Hydroxychloroquine (Plaquenil) Sales, Revenue and Gross Margin (2019-2024)
        7.6.4 Cardinal Health Hydroxychloroquine (Plaquenil) Product Offerings
        7.6.5 Cardinal Health Recent Development
    7.7 Apotex Corporation
        7.7.1 Apotex Corporation Company Information
        7.7.2 Apotex Corporation Introduction and Business Overview
        7.7.3 Apotex Corporation Hydroxychloroquine (Plaquenil) Sales, Revenue and Gross Margin (2019-2024)
        7.7.4 Apotex Corporation Hydroxychloroquine (Plaquenil) Product Offerings
        7.7.5 Apotex Corporation Recent Development
    7.8 Hikma Pharmaceuticals
        7.8.1 Hikma Pharmaceuticals Company Information
        7.8.2 Hikma Pharmaceuticals Introduction and Business Overview
        7.8.3 Hikma Pharmaceuticals Hydroxychloroquine (Plaquenil) Sales, Revenue and Gross Margin (2019-2024)
        7.8.4 Hikma Pharmaceuticals Hydroxychloroquine (Plaquenil) Product Offerings
        7.8.5 Hikma Pharmaceuticals Recent Development
    7.9 Aphena Pharma
        7.9.1 Aphena Pharma Company Information
        7.9.2 Aphena Pharma Introduction and Business Overview
        7.9.3 Aphena Pharma Hydroxychloroquine (Plaquenil) Sales, Revenue and Gross Margin (2019-2024)
        7.9.4 Aphena Pharma Hydroxychloroquine (Plaquenil) Product Offerings
        7.9.5 Aphena Pharma Recent Development
    7.10 Concordia Healthcare
        7.10.1 Concordia Healthcare Company Information
        7.10.2 Concordia Healthcare Introduction and Business Overview
        7.10.3 Concordia Healthcare Hydroxychloroquine (Plaquenil) Sales, Revenue and Gross Margin (2019-2024)
        7.10.4 Concordia Healthcare Hydroxychloroquine (Plaquenil) Product Offerings
        7.10.5 Concordia Healthcare Recent Development
    7.11 AvKARE (Amneal Pharmaceuticals)
        7.11.1 AvKARE (Amneal Pharmaceuticals) Company Information
        7.11.2 AvKARE (Amneal Pharmaceuticals) Introduction and Business Overview
        7.11.3 AvKARE (Amneal Pharmaceuticals) Hydroxychloroquine (Plaquenil) Sales, Revenue and Gross Margin (2019-2024)
        7.11.4 AvKARE (Amneal Pharmaceuticals) Hydroxychloroquine (Plaquenil) Product Offerings
        7.11.5 AvKARE (Amneal Pharmaceuticals) Recent Development
    7.12 Ipca Laboratories
        7.12.1 Ipca Laboratories Company Information
        7.12.2 Ipca Laboratories Introduction and Business Overview
        7.12.3 Ipca Laboratories Hydroxychloroquine (Plaquenil) Sales, Revenue and Gross Margin (2019-2024)
        7.12.4 Ipca Laboratories Hydroxychloroquine (Plaquenil) Product Offerings
        7.12.5 Ipca Laboratories Recent Development
    7.13 Shanghai Pharmaceuticals Holding
        7.13.1 Shanghai Pharmaceuticals Holding Company Information
        7.13.2 Shanghai Pharmaceuticals Holding Introduction and Business Overview
        7.13.3 Shanghai Pharmaceuticals Holding Hydroxychloroquine (Plaquenil) Sales, Revenue and Gross Margin (2019-2024)
        7.13.4 Shanghai Pharmaceuticals Holding Hydroxychloroquine (Plaquenil) Product Offerings
        7.13.5 Shanghai Pharmaceuticals Holding Recent Development
    7.14 Taj Pharmaceuticals
        7.14.1 Taj Pharmaceuticals Company Information
        7.14.2 Taj Pharmaceuticals Introduction and Business Overview
        7.14.3 Taj Pharmaceuticals Hydroxychloroquine (Plaquenil) Sales, Revenue and Gross Margin (2019-2024)
        7.14.4 Taj Pharmaceuticals Hydroxychloroquine (Plaquenil) Product Offerings
        7.14.5 Taj Pharmaceuticals Recent Development
    7.15 Cinkate Corporation
        7.15.1 Cinkate Corporation Company Information
        7.15.2 Cinkate Corporation Introduction and Business Overview
        7.15.3 Cinkate Corporation Hydroxychloroquine (Plaquenil) Sales, Revenue and Gross Margin (2019-2024)
        7.15.4 Cinkate Corporation Hydroxychloroquine (Plaquenil) Product Offerings
        7.15.5 Cinkate Corporation Recent Development
    7.16 Cadila Healthcare
        7.16.1 Cadila Healthcare Company Information
        7.16.2 Cadila Healthcare Introduction and Business Overview
        7.16.3 Cadila Healthcare Hydroxychloroquine (Plaquenil) Sales, Revenue and Gross Margin (2019-2024)
        7.16.4 Cadila Healthcare Hydroxychloroquine (Plaquenil) Product Offerings
        7.16.5 Cadila Healthcare Recent Development
    7.17 Sun Pharma
        7.17.1 Sun Pharma Company Information
        7.17.2 Sun Pharma Introduction and Business Overview
        7.17.3 Sun Pharma Hydroxychloroquine (Plaquenil) Sales, Revenue and Gross Margin (2019-2024)
        7.17.4 Sun Pharma Hydroxychloroquine (Plaquenil) Product Offerings
        7.17.5 Sun Pharma Recent Development
    7.18 Zydus Cadila
        7.18.1 Zydus Cadila Company Information
        7.18.2 Zydus Cadila Introduction and Business Overview
        7.18.3 Zydus Cadila Hydroxychloroquine (Plaquenil) Sales, Revenue and Gross Margin (2019-2024)
        7.18.4 Zydus Cadila Hydroxychloroquine (Plaquenil) Product Offerings
        7.18.5 Zydus Cadila Recent Development
    7.19 Advanz Pharma
        7.19.1 Advanz Pharma Company Information
        7.19.2 Advanz Pharma Introduction and Business Overview
        7.19.3 Advanz Pharma Hydroxychloroquine (Plaquenil) Sales, Revenue and Gross Margin (2019-2024)
        7.19.4 Advanz Pharma Hydroxychloroquine (Plaquenil) Product Offerings
        7.19.5 Advanz Pharma Recent Development
    7.20 Bristol Laboratories
        7.20.1 Bristol Laboratories Company Information
        7.20.2 Bristol Laboratories Introduction and Business Overview
        7.20.3 Bristol Laboratories Hydroxychloroquine (Plaquenil) Sales, Revenue and Gross Margin (2019-2024)
        7.20.4 Bristol Laboratories Hydroxychloroquine (Plaquenil) Product Offerings
        7.20.5 Bristol Laboratories Recent Development
    7.21 Hanlim Pharmaceutical
        7.21.1 Hanlim Pharmaceutical Company Information
        7.21.2 Hanlim Pharmaceutical Introduction and Business Overview
        7.21.3 Hanlim Pharmaceutical Hydroxychloroquine (Plaquenil) Sales, Revenue and Gross Margin (2019-2024)
        7.21.4 Hanlim Pharmaceutical Hydroxychloroquine (Plaquenil) Product Offerings
        7.21.5 Hanlim Pharmaceutical Recent Development
    7.22 Kyung Poong
        7.22.1 Kyung Poong Company Information
        7.22.2 Kyung Poong Introduction and Business Overview
        7.22.3 Kyung Poong Hydroxychloroquine (Plaquenil) Sales, Revenue and Gross Margin (2019-2024)
        7.22.4 Kyung Poong Hydroxychloroquine (Plaquenil) Product Offerings
        7.22.5 Kyung Poong Recent Development

 8 Industry Chain Analysis
    8.1 Hydroxychloroquine (Plaquenil) Industrial Chain
    8.2 Hydroxychloroquine (Plaquenil) Upstream Analysis
        8.2.1 Key Raw Materials
        8.2.2 Raw Materials Key Suppliers
        8.2.3 Manufacturing Cost Structure
    8.3 Midstream Analysis
    8.4 Downstream Analysis (Customers Analysis)
    8.5 Sales Model and Sales Channels
        8.5.1 Hydroxychloroquine (Plaquenil) Sales Model
        8.5.2 Sales Channel
        8.5.3 Hydroxychloroquine (Plaquenil) Distributors

 9 Research Findings and Conclusion

 10 Appendix
    10.1 Research Methodology
        10.1.1 Methodology/Research Approach
        10.1.2 Data Source
    10.2 Author Details
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Hydroxychloroquine (Plaquenil) Market Trends
    Table 2. Hydroxychloroquine (Plaquenil) Market Drivers & Opportunity
    Table 3. Hydroxychloroquine (Plaquenil) Market Challenges
    Table 4. Hydroxychloroquine (Plaquenil) Market Restraints
    Table 5. Global Hydroxychloroquine (Plaquenil) Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Hydroxychloroquine (Plaquenil) Revenue Market Share by Company (2019-2024)
    Table 7. Global Hydroxychloroquine (Plaquenil) Sales Volume by Company (2019-2024) & (M Pcs)
    Table 8. Global Hydroxychloroquine (Plaquenil) Sales Volume Market Share by Company (2019-2024)
    Table 9. Global Market Hydroxychloroquine (Plaquenil) Price by Company (2019-2024) & (US$/Pcs)
    Table 10. Key Manufacturers Hydroxychloroquine (Plaquenil) Manufacturing Base Distribution and Headquarters
    Table 11. Key Manufacturers Hydroxychloroquine (Plaquenil) Product Type
    Table 12. Key Manufacturers Time to Begin Mass Production of Hydroxychloroquine (Plaquenil)
    Table 13. Global Hydroxychloroquine (Plaquenil) Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hydroxychloroquine (Plaquenil) as of 2023)
    Table 15. Mergers & Acquisitions, Expansion Plans
    Table 16. Global Hydroxychloroquine (Plaquenil) Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 17. Global Hydroxychloroquine (Plaquenil) Sales Value by Type (2019-2024) & (US$ Million)
    Table 18. Global Hydroxychloroquine (Plaquenil) Sales Value by Type (2025-2030) & (US$ Million)
    Table 19. Global Hydroxychloroquine (Plaquenil) Sales Market Share in Value by Type (2019-2024) & (%)
    Table 20. Global Hydroxychloroquine (Plaquenil) Sales Market Share in Value by Type (2025-2030) & (%)
    Table 21. Global Hydroxychloroquine (Plaquenil) Sales Volume by Type: 2019 VS 2023 VS 2030 (M Pcs)
    Table 22. Global Hydroxychloroquine (Plaquenil) Sales Volume by Type (2019-2024) & (M Pcs)
    Table 23. Global Hydroxychloroquine (Plaquenil) Sales Volume by Type (2025-2030) & (M Pcs)
    Table 24. Global Hydroxychloroquine (Plaquenil) Sales Market Share in Volume by Type (2019-2024) & (%)
    Table 25. Global Hydroxychloroquine (Plaquenil) Sales Market Share in Volume by Type (2025-2030) & (%)
    Table 26. Global Hydroxychloroquine (Plaquenil) Price by Type (2019-2024) & (US$/Pcs)
    Table 27. Global Hydroxychloroquine (Plaquenil) Price by Type (2025-2030) & (US$/Pcs)
    Table 28. Global Hydroxychloroquine (Plaquenil) Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 29. Global Hydroxychloroquine (Plaquenil) Sales Value by Application (2019-2024) & (US$ Million)
    Table 30. Global Hydroxychloroquine (Plaquenil) Sales Value by Application (2025-2030) & (US$ Million)
    Table 31. Global Hydroxychloroquine (Plaquenil) Sales Market Share in Value by Application (2019-2024) & (%)
    Table 32. Global Hydroxychloroquine (Plaquenil) Sales Market Share in Value by Application (2025-2030) & (%)
    Table 33. Global Hydroxychloroquine (Plaquenil) Sales Volume by Application: 2019 VS 2023 VS 2030 (M Pcs)
    Table 34. Global Hydroxychloroquine (Plaquenil) Sales Volume by Application (2019-2024) & (M Pcs)
    Table 35. Global Hydroxychloroquine (Plaquenil) Sales Volume by Application (2025-2030) & (M Pcs)
    Table 36. Global Hydroxychloroquine (Plaquenil) Sales Market Share in Volume by Application (2019-2024) & (%)
    Table 37. Global Hydroxychloroquine (Plaquenil) Sales Market Share in Volume by Application (2025-2030) & (%)
    Table 38. Global Hydroxychloroquine (Plaquenil) Price by Application (2019-2024) & (US$/Pcs)
    Table 39. Global Hydroxychloroquine (Plaquenil) Price by Application (2025-2030) & (US$/Pcs)
    Table 40. Global Hydroxychloroquine (Plaquenil) Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Global Hydroxychloroquine (Plaquenil) Sales Value by Region (2019-2024) & (US$ Million)
    Table 42. Global Hydroxychloroquine (Plaquenil) Sales Value by Region (2025-2030) & (US$ Million)
    Table 43. Global Hydroxychloroquine (Plaquenil) Sales Value by Region (2019-2024) & (%)
    Table 44. Global Hydroxychloroquine (Plaquenil) Sales Value by Region (2025-2030) & (%)
    Table 45. Global Hydroxychloroquine (Plaquenil) Sales Volume by Region (M Pcs): 2019 VS 2023 VS 2030
    Table 46. Global Hydroxychloroquine (Plaquenil) Sales Volume by Region (2019-2024) & (M Pcs)
    Table 47. Global Hydroxychloroquine (Plaquenil) Sales Volume by Region (2025-2030) & (M Pcs)
    Table 48. Global Hydroxychloroquine (Plaquenil) Sales Volume by Region (2019-2024) & (%)
    Table 49. Global Hydroxychloroquine (Plaquenil) Sales Volume by Region (2025-2030) & (%)
    Table 50. Global Hydroxychloroquine (Plaquenil) Average Price by Region (2019-2024) & (US$/Pcs)
    Table 51. Global Hydroxychloroquine (Plaquenil) Average Price by Region (2025-2030) & (US$/Pcs)
    Table 52. Key Countries/Regions Hydroxychloroquine (Plaquenil) Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 53. Key Countries/Regions Hydroxychloroquine (Plaquenil) Sales Value, (2019-2024) & (US$ Million)
    Table 54. Key Countries/Regions Hydroxychloroquine (Plaquenil) Sales Value, (2025-2030) & (US$ Million)
    Table 55. Key Countries/Regions Hydroxychloroquine (Plaquenil) Sales Volume, (2019-2024) & (M Pcs)
    Table 56. Key Countries/Regions Hydroxychloroquine (Plaquenil) Sales Volume, (2025-2030) & (M Pcs)
    Table 57. Sanofi Company Information
    Table 58. Sanofi Introduction and Business Overview
    Table 59. Sanofi Hydroxychloroquine (Plaquenil) Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2019-2024)
    Table 60. Sanofi Hydroxychloroquine (Plaquenil) Product Offerings
    Table 61. Sanofi Recent Development
    Table 62. Actavis (TEVA ) Company Information
    Table 63. Actavis (TEVA ) Introduction and Business Overview
    Table 64. Actavis (TEVA ) Hydroxychloroquine (Plaquenil) Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2019-2024)
    Table 65. Actavis (TEVA ) Hydroxychloroquine (Plaquenil) Product Offerings
    Table 66. Actavis (TEVA ) Recent Development
    Table 67. Mylan Company Information
    Table 68. Mylan Introduction and Business Overview
    Table 69. Mylan Hydroxychloroquine (Plaquenil) Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2019-2024)
    Table 70. Mylan Hydroxychloroquine (Plaquenil) Product Offerings
    Table 71. Mylan Recent Development
    Table 72. Novartis Company Information
    Table 73. Novartis Introduction and Business Overview
    Table 74. Novartis Hydroxychloroquine (Plaquenil) Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2019-2024)
    Table 75. Novartis Hydroxychloroquine (Plaquenil) Product Offerings
    Table 76. Novartis Recent Development
    Table 77. Covis Pharmaceutical Company Information
    Table 78. Covis Pharmaceutical Introduction and Business Overview
    Table 79. Covis Pharmaceutical Hydroxychloroquine (Plaquenil) Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2019-2024)
    Table 80. Covis Pharmaceutical Hydroxychloroquine (Plaquenil) Product Offerings
    Table 81. Covis Pharmaceutical Recent Development
    Table 82. Cardinal Health Company Information
    Table 83. Cardinal Health Introduction and Business Overview
    Table 84. Cardinal Health Hydroxychloroquine (Plaquenil) Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2019-2024)
    Table 85. Cardinal Health Hydroxychloroquine (Plaquenil) Product Offerings
    Table 86. Cardinal Health Recent Development
    Table 87. Apotex Corporation Company Information
    Table 88. Apotex Corporation Introduction and Business Overview
    Table 89. Apotex Corporation Hydroxychloroquine (Plaquenil) Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2019-2024)
    Table 90. Apotex Corporation Hydroxychloroquine (Plaquenil) Product Offerings
    Table 91. Apotex Corporation Recent Development
    Table 92. Hikma Pharmaceuticals Company Information
    Table 93. Hikma Pharmaceuticals Introduction and Business Overview
    Table 94. Hikma Pharmaceuticals Hydroxychloroquine (Plaquenil) Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2019-2024)
    Table 95. Hikma Pharmaceuticals Hydroxychloroquine (Plaquenil) Product Offerings
    Table 96. Hikma Pharmaceuticals Recent Development
    Table 97. Aphena Pharma Company Information
    Table 98. Aphena Pharma Introduction and Business Overview
    Table 99. Aphena Pharma Hydroxychloroquine (Plaquenil) Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2019-2024)
    Table 100. Aphena Pharma Hydroxychloroquine (Plaquenil) Product Offerings
    Table 101. Aphena Pharma Recent Development
    Table 102. Concordia Healthcare Company Information
    Table 103. Concordia Healthcare Introduction and Business Overview
    Table 104. Concordia Healthcare Hydroxychloroquine (Plaquenil) Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2019-2024)
    Table 105. Concordia Healthcare Hydroxychloroquine (Plaquenil) Product Offerings
    Table 106. Concordia Healthcare Recent Development
    Table 107. AvKARE (Amneal Pharmaceuticals) Company Information
    Table 108. AvKARE (Amneal Pharmaceuticals) Introduction and Business Overview
    Table 109. AvKARE (Amneal Pharmaceuticals) Hydroxychloroquine (Plaquenil) Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2019-2024)
    Table 110. AvKARE (Amneal Pharmaceuticals) Hydroxychloroquine (Plaquenil) Product Offerings
    Table 111. AvKARE (Amneal Pharmaceuticals) Recent Development
    Table 112. Ipca Laboratories Company Information
    Table 113. Ipca Laboratories Introduction and Business Overview
    Table 114. Ipca Laboratories Hydroxychloroquine (Plaquenil) Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2019-2024)
    Table 115. Ipca Laboratories Hydroxychloroquine (Plaquenil) Product Offerings
    Table 116. Ipca Laboratories Recent Development
    Table 117. Shanghai Pharmaceuticals Holding Company Information
    Table 118. Shanghai Pharmaceuticals Holding Introduction and Business Overview
    Table 119. Shanghai Pharmaceuticals Holding Hydroxychloroquine (Plaquenil) Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2019-2024)
    Table 120. Shanghai Pharmaceuticals Holding Hydroxychloroquine (Plaquenil) Product Offerings
    Table 121. Shanghai Pharmaceuticals Holding Recent Development
    Table 122. Taj Pharmaceuticals Company Information
    Table 123. Taj Pharmaceuticals Introduction and Business Overview
    Table 124. Taj Pharmaceuticals Hydroxychloroquine (Plaquenil) Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2019-2024)
    Table 125. Taj Pharmaceuticals Hydroxychloroquine (Plaquenil) Product Offerings
    Table 126. Taj Pharmaceuticals Recent Development
    Table 127. Cinkate Corporation Company Information
    Table 128. Cinkate Corporation Introduction and Business Overview
    Table 129. Cinkate Corporation Hydroxychloroquine (Plaquenil) Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2019-2024)
    Table 130. Cinkate Corporation Hydroxychloroquine (Plaquenil) Product Offerings
    Table 131. Cinkate Corporation Recent Development
    Table 132. Cadila Healthcare Company Information
    Table 133. Cadila Healthcare Introduction and Business Overview
    Table 134. Cadila Healthcare Hydroxychloroquine (Plaquenil) Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2019-2024)
    Table 135. Cadila Healthcare Hydroxychloroquine (Plaquenil) Product Offerings
    Table 136. Cadila Healthcare Recent Development
    Table 137. Sun Pharma Company Information
    Table 138. Sun Pharma Introduction and Business Overview
    Table 139. Sun Pharma Hydroxychloroquine (Plaquenil) Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2019-2024)
    Table 140. Sun Pharma Hydroxychloroquine (Plaquenil) Product Offerings
    Table 141. Sun Pharma Recent Development
    Table 142. Zydus Cadila Company Information
    Table 143. Zydus Cadila Introduction and Business Overview
    Table 144. Zydus Cadila Hydroxychloroquine (Plaquenil) Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2019-2024)
    Table 145. Zydus Cadila Hydroxychloroquine (Plaquenil) Product Offerings
    Table 146. Zydus Cadila Recent Development
    Table 147. Advanz Pharma Company Information
    Table 148. Advanz Pharma Introduction and Business Overview
    Table 149. Advanz Pharma Hydroxychloroquine (Plaquenil) Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2019-2024)
    Table 150. Advanz Pharma Hydroxychloroquine (Plaquenil) Product Offerings
    Table 151. Advanz Pharma Recent Development
    Table 152. Bristol Laboratories Company Information
    Table 153. Bristol Laboratories Introduction and Business Overview
    Table 154. Bristol Laboratories Hydroxychloroquine (Plaquenil) Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2019-2024)
    Table 155. Bristol Laboratories Hydroxychloroquine (Plaquenil) Product Offerings
    Table 156. Bristol Laboratories Recent Development
    Table 157. Hanlim Pharmaceutical Company Information
    Table 158. Hanlim Pharmaceutical Introduction and Business Overview
    Table 159. Hanlim Pharmaceutical Hydroxychloroquine (Plaquenil) Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2019-2024)
    Table 160. Hanlim Pharmaceutical Hydroxychloroquine (Plaquenil) Product Offerings
    Table 161. Hanlim Pharmaceutical Recent Development
    Table 162. Kyung Poong Company Information
    Table 163. Kyung Poong Introduction and Business Overview
    Table 164. Kyung Poong Hydroxychloroquine (Plaquenil) Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2019-2024)
    Table 165. Kyung Poong Hydroxychloroquine (Plaquenil) Product Offerings
    Table 166. Kyung Poong Recent Development
    Table 167. Key Raw Materials Lists
    Table 168. Raw Materials Key Suppliers Lists
    Table 169. Hydroxychloroquine (Plaquenil) Downstream Customers
    Table 170. Hydroxychloroquine (Plaquenil) Distributors List
    Table 171. Research Programs/Design for This Report
    Table 172. Key Data Information from Secondary Sources
    Table 173. Key Data Information from Primary Sources
List of Figures
    Figure 1. Hydroxychloroquine (Plaquenil) Product Picture
    Figure 2. Global Hydroxychloroquine (Plaquenil) Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Hydroxychloroquine (Plaquenil) Sales Value (2019-2030) & (US$ Million)
    Figure 4. Global Hydroxychloroquine (Plaquenil) Sales Volume (2019-2030) & (M Pcs)
    Figure 5. Global Hydroxychloroquine (Plaquenil) Sales Price (2019-2030) & (US$/Pcs)
    Figure 6. Hydroxychloroquine (Plaquenil) Report Years Considered
    Figure 7. Global Hydroxychloroquine (Plaquenil) Players Revenue Ranking (2023) & (US$ Million)
    Figure 8. Global Hydroxychloroquine (Plaquenil) Players Sales Volume Ranking (2023) & (M Pcs)
    Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Hydroxychloroquine (Plaquenil) Revenue in 2023
    Figure 10. Hydroxychloroquine (Plaquenil) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 11. 100mg Picture
    Figure 12. 200mg Picture
    Figure 13. Other Picture
    Figure 14. Global Hydroxychloroquine (Plaquenil) Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 15. Global Hydroxychloroquine (Plaquenil) Sales Value Market Share by Type, 2023 & 2030
    Figure 16. Global Hydroxychloroquine (Plaquenil) Sales Volume by Type (2019 VS 2023 VS 2030) & (M Pcs)
    Figure 17. Global Hydroxychloroquine (Plaquenil) Sales Volume Market Share by Type, 2023 & 2030
    Figure 18. Global Hydroxychloroquine (Plaquenil) Price by Type (2019-2030) & (US$/Pcs)
    Figure 19. Product Picture of Lupus Erythematosus
    Figure 20. Product Picture of Rheumatoid Arthritis
    Figure 21. Product Picture of COVID-19
    Figure 22. Product Picture of Others
    Figure 23. Global Hydroxychloroquine (Plaquenil) Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 24. Global Hydroxychloroquine (Plaquenil) Sales Value Market Share by Application, 2023 & 2030
    Figure 25. Global Hydroxychloroquine (Plaquenil) Sales Volume by Application (2019 VS 2023 VS 2030) & (M Pcs)
    Figure 26. Global Hydroxychloroquine (Plaquenil) Sales Volume Market Share by Application, 2023 & 2030
    Figure 27. Global Hydroxychloroquine (Plaquenil) Price by Application (2019-2030) & (US$/Pcs)
    Figure 28. North America Hydroxychloroquine (Plaquenil) Sales Value (2019-2030) & (US$ Million)
    Figure 29. North America Hydroxychloroquine (Plaquenil) Sales Value by Country (%), 2023 VS 2030
    Figure 30. Europe Hydroxychloroquine (Plaquenil) Sales Value (2019-2030) & (US$ Million)
    Figure 31. Europe Hydroxychloroquine (Plaquenil) Sales Value by Country (%), 2023 VS 2030
    Figure 32. Asia Pacific Hydroxychloroquine (Plaquenil) Sales Value (2019-2030) & (US$ Million)
    Figure 33. Asia Pacific Hydroxychloroquine (Plaquenil) Sales Value by Country (%), 2023 VS 2030
    Figure 34. South America Hydroxychloroquine (Plaquenil) Sales Value (2019-2030) & (US$ Million)
    Figure 35. South America Hydroxychloroquine (Plaquenil) Sales Value by Country (%), 2023 VS 2030
    Figure 36. Middle East & Africa Hydroxychloroquine (Plaquenil) Sales Value (2019-2030) & (US$ Million)
    Figure 37. Middle East & Africa Hydroxychloroquine (Plaquenil) Sales Value by Country (%), 2023 VS 2030
    Figure 38. Key Countries/Regions Hydroxychloroquine (Plaquenil) Sales Value (%), (2019-2030)
    Figure 39. Key Countries/Regions Hydroxychloroquine (Plaquenil) Sales Volume (%), (2019-2030)
    Figure 40. United States Hydroxychloroquine (Plaquenil) Sales Value, (2019-2030) & (US$ Million)
    Figure 41. United States Hydroxychloroquine (Plaquenil) Sales Value by Type (%), 2023 VS 2030
    Figure 42. United States Hydroxychloroquine (Plaquenil) Sales Value by Application (%), 2023 VS 2030
    Figure 43. Europe Hydroxychloroquine (Plaquenil) Sales Value, (2019-2030) & (US$ Million)
    Figure 44. Europe Hydroxychloroquine (Plaquenil) Sales Value by Type (%), 2023 VS 2030
    Figure 45. Europe Hydroxychloroquine (Plaquenil) Sales Value by Application (%), 2023 VS 2030
    Figure 46. China Hydroxychloroquine (Plaquenil) Sales Value, (2019-2030) & (US$ Million)
    Figure 47. China Hydroxychloroquine (Plaquenil) Sales Value by Type (%), 2023 VS 2030
    Figure 48. China Hydroxychloroquine (Plaquenil) Sales Value by Application (%), 2023 VS 2030
    Figure 49. Japan Hydroxychloroquine (Plaquenil) Sales Value, (2019-2030) & (US$ Million)
    Figure 50. Japan Hydroxychloroquine (Plaquenil) Sales Value by Type (%), 2023 VS 2030
    Figure 51. Japan Hydroxychloroquine (Plaquenil) Sales Value by Application (%), 2023 VS 2030
    Figure 52. South Korea Hydroxychloroquine (Plaquenil) Sales Value, (2019-2030) & (US$ Million)
    Figure 53. South Korea Hydroxychloroquine (Plaquenil) Sales Value by Type (%), 2023 VS 2030
    Figure 54. South Korea Hydroxychloroquine (Plaquenil) Sales Value by Application (%), 2023 VS 2030
    Figure 55. Southeast Asia Hydroxychloroquine (Plaquenil) Sales Value, (2019-2030) & (US$ Million)
    Figure 56. Southeast Asia Hydroxychloroquine (Plaquenil) Sales Value by Type (%), 2023 VS 2030
    Figure 57. Southeast Asia Hydroxychloroquine (Plaquenil) Sales Value by Application (%), 2023 VS 2030
    Figure 58. India Hydroxychloroquine (Plaquenil) Sales Value, (2019-2030) & (US$ Million)
    Figure 59. India Hydroxychloroquine (Plaquenil) Sales Value by Type (%), 2023 VS 2030
    Figure 60. India Hydroxychloroquine (Plaquenil) Sales Value by Application (%), 2023 VS 2030
    Figure 61. Hydroxychloroquine (Plaquenil) Industrial Chain
    Figure 62. Hydroxychloroquine (Plaquenil) Manufacturing Cost Structure
    Figure 63. Channels of Distribution (Direct Sales, and Distribution)
    Figure 64. Bottom-up and Top-down Approaches for This Report
    Figure 65. Data Triangulation
    Figure 66. Key Executives Interviewed

Description

Hydroxychloroquine is a racemic mixture consisting of an R and S enantiomer.2 Hydroxychloroquine is an aminoquinoline like chloroquine. It is a commonly prescribed medication in the treatment of uncomplicated malaria, rheumatoid arthritis, chronic discoid lupus erythematosus, and systemic lupus erythematosus. Hydroxychloroquine is also used for the prophylaxis of malaria in regions where chloroquine resistance is unlikely. It was developed during World War II as a derivative of quinacrine with less severe side effects.6 Chloroquine and hydroxychloroquine are both being investigated for the treatment of SARS-CoV-2.7It is taken by mouth.[2] It is also being used as an experimental treatment for coronavirus disease 2019 (COVID-19).

The global market for Hydroxychloroquine (Plaquenil) was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.

North American market for Hydroxychloroquine (Plaquenil) was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Hydroxychloroquine (Plaquenil) was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Europe market for Hydroxychloroquine (Plaquenil) was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The global key companies of Hydroxychloroquine (Plaquenil) include Sanofi, Actavis (TEVA ), Mylan, Novartis, Covis Pharmaceutical, Cardinal Health, Apotex Corporation, Hikma Pharmaceuticals and Aphena Pharma, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.

Report Scope
This report aims to provide a comprehensive presentation of the global market for Hydroxychloroquine (Plaquenil), focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Hydroxychloroquine (Plaquenil) by region & country, by Type, and by Application.

The Hydroxychloroquine (Plaquenil) market size, estimations, and forecasts are provided in terms of sales volume (M Pcs) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hydroxychloroquine (Plaquenil).

Market Segmentation